ImmunoGen Needs Another Phase III For Its ADC In Ovarian Cancer

 
• By Joseph Haas
  
business, education and office people concept - businessman or teacher with marker writing or drawing something on white blank board over concrete wall background from back - Image
ImmunoGen is back to the drawing board, needing a new Phase III for its ADC in ovarian cancer
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D